Up to 15,000 could be given nivolumab in injectable form to treat 15 cancers including lung, bowel and skin cancer
Up to 15,000 cancer patients a year could be treated with a quick injection, NHS England announced on Wednesday.
It is the first health service in Europe to offer patients the injectable form of the immunotherapy drug nivolumab.
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
DNA testing firm 23andMe fined £2.3m by UK regulator for 2023 data hack